Skip to content
Riskpilot
← Back to search
Sign in
Get full access
HEMODX AS
AS
Active
Org 925006939
Skogfaret 25B, 0382
Oslo
Diagnostic imaging services and medical laboratory activities
·
NACE 8691
Est. 2020 · 6 years old
3 employees
Monitor
Share
Norway
/
Companies
/
Diagnostic imaging services and medical laboratory activities
/
HEMODX AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
0M
1M
1M
2M
2M
1M
2020
0M
2021
1M
2022
2M
2023
0M
2024
EBITDA
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2020
-1M
-100%
2021
0M
+100%
2022
-1M
-100%
2023
-1M
0%
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
550
278
1 180
2 450
440
Staff expenses
−403
−597
−451
−1 787
−1 793
EBITDA
5
−627
436
−1 496
−1 494
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
5
−627
436
−1 496
−1 494
Net financials
0
−25
−26
4
18
Profit before tax
5
−652
410
−1 492
−1 476
Tax
1
−0
−0
−0
−0
Net profit
4
−652
410
−1 492
−1 476
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
414
447
1 507
2 488
1 045
Equity
34
−123
787
49
−1 427
Long-term debt
0
0
0
1 785
1 985
Short-term debt
380
570
720
654
487
Total debt
380
570
720
2 439
2 472
Financial ratios
5-year trend
EBITDA margin
-339.6%
This company
15.8%
Market median
-2249% vs market
2020
2024
Equity ratio
-136.5%
This company
38.2%
Market median
-457% vs market
2020
2024
Return on equity
-147578800.0%
This company
18.4%
Market median
-802058796% vs market
2020
2024
Net profit margin
-335.4%
This company
8.1%
Market median
-4241% vs market
2020
2024
Asset turnover
0.42×
This company
1.12×
Market median
-63% vs market
2020
2024
Debt / equity
1.73×
This company
0.62×
Market median
-179% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-04-17 – 2020-12-31
View
PDF
More on HEMODX AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
